Evidence map›Paper›PMID 24725831›Full record

ArticleThe Annals of thoracic surgery2014

Association between preoperative statin use and acute kidney injury biomarkers in cardiac surgical procedures.

Amber O Molnar, Chirag R Parikh, Steven G Coca, Heather Thiessen-Philbrook, Jay L Koyner, Michael G Shlipak, Mary Lee Myers, Amit X Garg, TRIBE-AKI Consortium

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in The Annals of thoracic surgery, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 3 pooled it
4.8field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 3 syntheses or guidelines pooled it, 48 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Article
  8. Article
  9. Article
  10. Biomarkers of Acute and Chronic Kidney Disease.Annual review of physiology · 2019
    Review
  11. Acute kidney injury after cardiac surgery: prevalence, impact and management challenges.International journal of nephrology and renovascular disease · 2019
    Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 6 institutions in 2 countries.

Amber O MolnarDivision of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Chirag R ParikhSection of Nephrology, Yale University School of Medicine, Veterans Affairs CT Healthcare System, and the Program of Applied Translational Research, New Haven, Connecticut; Department of Medicine, Veterans Affairs Medical Center, West Haven, Connecticut. Electronic address: chirag.parikh@yale.edu.
Steven G CocaSection of Nephrology, Yale University School of Medicine, Veterans Affairs CT Healthcare System, and the Program of Applied Translational Research, New Haven, Connecticut.
Heather Thiessen-PhilbrookDivision of Nephrology, Department of Medicine, Western University, London, Ontario, Canada.
Jay L KoynerSection of Nephrology, Department of Medicine, University of Chicago, Pritzker School of Medicine, Chicago, Illinois.
Michael G ShlipakDivision of General Internal Medicine, San Francisco Veterans Affairs Medical Center, University of California, San Francisco, California.
Mary Lee MyersDivision of Cardiac Surgery, Western University, London, Ontario, Canada.
Amit X GargDivision of Nephrology, Department of Medicine, Western University, London, Ontario, Canada; Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada; Department of Epidemiology & Biostatistics, Western University, London, Ontario, Canada; Institute for Clinical Evaluative Sciences, Toronto, Ontario, Canada.
TRIBE-AKI Consortium
Western University · CAConnecticut Health Foundation · USSan Francisco VA Medical Center · USUniversity of Chicago · USUniversity of Ottawa · CAVA Connecticut Healthcare System · US

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S. · 2008 to 2022
$16.8M
Novel Biomarkers in Cardiac Surgery to Detect Acute Kidney InjuryR01HL085757 · NHLBI · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2007 to 2019
$10.3M
Progression of Acute Kidney Injury to Chronic Kidney DiseaseU01DK082185 · NIDDK · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2008 to 2017
$5.1M
Novel serum and urinary biomarkers of diabetic kidney diseaseR01DK096549 · NIDDK · YALE UNIVERSITY · PI COCA, STEVEN G · 2012 to 2016
$2.9M
Long-term Prognosis of Acute Kidney Injury in Cardiac SurgeryK23DK080132 · NIDDK · YALE UNIVERSITY · PI COCA, STEVEN G · 2008 to 2012
$957k
Mentoring Program for Translational and Patient Oriented Research in AKIK24DK090203 · NIDDK · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2012 to 2016
$896k
NCATS NIH HHS UL1 TR000430NHLBI NIH HHS R01 HL085757NHLBI NIH HHS R01HL085757NIDDK NIH HHS K23 DK080132NIDDK NIH HHS K23DK080132NIDDK NIH HHS K24 DK090203NIDDK NIH HHS K24DK090203NIDDK NIH HHS P30 DK079310NIDDK NIH HHS R01 DK096549NIDDK NIH HHS R01DK096549NIDDK NIH HHS U01 DK082185NIDDK NIH HHS U01DK082185
6 · The paper itself

Abstract

backgroundAcute kidney injury (AKI) is a serious complication of cardiac operations for which there remains no specific therapy. Animal data and several observational studies suggest that statins prevent AKI, but the results are not conclusive, and many studies are retrospective in nature.

methodsWe conducted a multicenter prospective cohort study of 625 adult patients undergoing elective cardiac operations. All patients were taking statins and were grouped according to whether statins were continued or held in the 24 hours before operation. The primary outcome was AKI as defined by a doubling of serum creatinine or dialysis. The secondary outcome was the peak level of several kidney injury biomarkers. The results were adjusted for demographic and clinical factors.

resultsContinuing (vs holding) a statin before operation was not associated with a lower risk of AKI, as defined by a doubling of serum creatinine or dialysis (adjusted relative risk [RR] 1.09; 95% confidence interval [CI] 0.44, 2.70). However, continuing a statin was associated with a lower risk of elevation of the following AKI biomarkers: urine interleukin-18, urine neutrophil gelatinase-associated lipocalin, urine kidney injury molecule-1, and plasma neutrophil gelatinase-associated lipocalin (adjusted RR 0.34; 95% CI 0.18, 0.62), (adjusted RR 0.41; 95% CI 0.22, 0.76), (adjusted RR 0.37; 95% CI 0.20, 0.76), (adjusted RR 0.62; 95% CI 0.39, 0.98), respectively.

conclusionsStatins may prevent kidney injury after cardiac operations, as evidenced by lower levels of kidney injury biomarkers.

Indexed as

Acute Kidney InjuryAcute-Phase ProteinsAdultAgedBiomarkersCardiac Surgical ProceduresCohort StudiesFemaleHepatitis A Virus Cellular Receptor 1HumansHydroxymethylglutaryl-CoA Reductase InhibitorsInterleukin-18Lipocalin-2LipocalinsMaleMembrane GlycoproteinsAcute-Phase ProteinsBiomarkersHAVCR1 protein, humanHepatitis A Virus Cellular Receptor 1Hydroxymethylglutaryl-CoA Reductase InhibitorsInterleukin-18LCN2 protein, humanLipocalin-2LipocalinsMembrane GlycoproteinsProto-Oncogene ProteinsReceptors, Virus

Identifiers

PMID24725831
PMCPMC4068122
OpenAlexW2043428517

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.